Regentatlantic Capital LLC Boston Scientific Corp Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 29,939 shares of BSX stock, worth $2.95 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
29,939
Previous 33,771
11.35%
Holding current value
$2.95 Million
Previous $1.26 Million
7.86%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding BSX
# of Institutions
1,559Shares Held
1.18BCall Options Held
6.78MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$13 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.2 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.73 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.24 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $141B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...